Franziska Szelinski

1.5k total citations
22 papers, 384 citations indexed

About

Franziska Szelinski is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Franziska Szelinski has authored 22 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Rheumatology and 6 papers in Molecular Biology. Recurrent topics in Franziska Szelinski's work include Systemic Lupus Erythematosus Research (10 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (5 papers). Franziska Szelinski is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), T-cell and B-cell Immunology (10 papers) and Immune Cell Function and Interaction (5 papers). Franziska Szelinski collaborates with scholars based in Germany, Colombia and Switzerland. Franziska Szelinski's co-authors include Thomas Dörner, Andreia C. Lino, Eva Schrezenmeier, Thomas Rose, Annika Wiedemann, Karin Reiter, Ana‐Luisa Stefanski, Gerd R Burmester, Héctor Rincón-Arévalo and Andreas Radbruch and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Franziska Szelinski

19 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franziska Szelinski Germany 11 242 169 69 58 44 22 384
Huaqun Zhu China 11 322 1.3× 131 0.8× 89 1.3× 72 1.2× 20 0.5× 23 463
Olof Berggren Sweden 9 258 1.1× 176 1.0× 72 1.0× 41 0.7× 30 0.7× 14 367
Lucyna Korman Poland 12 163 0.7× 213 1.3× 48 0.7× 64 1.1× 29 0.7× 27 404
Alessandra Penatti Italy 7 226 0.9× 241 1.4× 73 1.1× 49 0.8× 53 1.2× 10 481
Kamini Shah United States 5 339 1.4× 168 1.0× 68 1.0× 62 1.1× 17 0.4× 9 423
Ling‐Ying Lu Taiwan 10 122 0.5× 158 0.9× 49 0.7× 35 0.6× 22 0.5× 31 311
Konstantia-Maria Chavele United Kingdom 6 266 1.1× 122 0.7× 75 1.1× 38 0.7× 42 1.0× 7 399
Quentin Simon France 10 335 1.4× 66 0.4× 63 0.9× 90 1.6× 47 1.1× 17 514
Takayoshi Morita Japan 10 257 1.1× 98 0.6× 58 0.8× 52 0.9× 16 0.4× 22 408
Afroditi Boulougoura United States 10 169 0.7× 103 0.6× 77 1.1× 34 0.6× 29 0.7× 20 372

Countries citing papers authored by Franziska Szelinski

Since Specialization
Citations

This map shows the geographic impact of Franziska Szelinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Szelinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Szelinski more than expected).

Fields of papers citing papers by Franziska Szelinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franziska Szelinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Szelinski. The network helps show where Franziska Szelinski may publish in the future.

Co-authorship network of co-authors of Franziska Szelinski

This figure shows the co-authorship network connecting the top 25 collaborators of Franziska Szelinski. A scholar is included among the top collaborators of Franziska Szelinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franziska Szelinski. Franziska Szelinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rincón-Arévalo, Héctor, Bilgin Osmanodja, Annika Wiedemann, et al.. (2025). Soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLE. SHILAP Revista de lepidopterología. 16. 1685275–1685275.
2.
Dang, Van Duc, Héctor Rincón-Arévalo, Franziska Szelinski, et al.. (2025). Phosphatidylcholine-specific B cells are enriched among atypical CD11chigh and CD21low memory B cells in antiphospholipid syndrome. Frontiers in Immunology. 16. 1585953–1585953.
3.
Gebhardt, Christoffer, Franziska Szelinski, Veit Buecklein, et al.. (2025). POS1113 TREATMENT OF SEVERE SYSTEMIC SCLEROSIS WITH BLINATUMOMAB, A BISPECIFIC ANTI-CD3/CD19 T CELL ENGAGER. Annals of the Rheumatic Diseases. 84. 1197–1197.
4.
Subklewe, Marion, Veit Bücklein, Franziska Szelinski, et al.. (2024). Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study. European Journal of Cancer. 204. 114071–114071. 33 indexed citations
5.
Ritter, Jacob, Franziska Szelinski, Ana‐Luisa Stefanski, et al.. (2024). Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets. Journal of Autoimmunity. 147. 103243–103243. 6 indexed citations
6.
Rincón-Arévalo, Héctor, Ana‐Luisa Stefanski, Tuấn Anh Lê, et al.. (2024). Differential response of IgM and IgG memory B cell populations to CD40L: insights of T cell – memory B cell interactions. Frontiers in Immunology. 15. 1432045–1432045. 1 indexed citations
7.
Wiedemann, Annika, Ana‐Luisa Stefanski, Franziska Szelinski, et al.. (2023). Transcriptional profiling upon T cell stimulation reveals down-regulation of inflammatory pathways in T and B cells in SLE versus Sjögren’s syndrome. npj Systems Biology and Applications. 9(1). 62–62. 2 indexed citations
8.
Dang, Van Duc, Elodie Mohr, Franziska Szelinski, et al.. (2022). CD39 and CD326 Are Bona Fide Markers of Murine and Human Plasma Cells and Identify a Bone Marrow Specific Plasma Cell Subpopulation in Lupus. Frontiers in Immunology. 13. 873217–873217. 6 indexed citations
9.
Szelinski, Franziska, Ana‐Luisa Stefanski, Eva Schrezenmeier, et al.. (2022). Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5 – CD19 low B Cells in Systemic Lupus Erythematosus. Arthritis & Rheumatology. 74(9). 1556–1568. 28 indexed citations
10.
Stefanski, Ana‐Luisa, Héctor Rincón-Arévalo, Eva Schrezenmeier, et al.. (2022). Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure. Frontiers in Immunology. 13. 943476–943476. 2 indexed citations
11.
Stefanski, Ana‐Luisa, Héctor Rincón-Arévalo, Eva Schrezenmeier, et al.. (2022). B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients. Frontiers in Immunology. 13. 822885–822885. 7 indexed citations
12.
Rincón-Arévalo, Héctor, Jacob Ritter, Franziska Szelinski, et al.. (2021). Altered increase in STAT1 expression and phosphorylation in severe COVID‐19. European Journal of Immunology. 52(1). 138–148. 35 indexed citations
13.
Szelinski, Franziska, Andreia C. Lino, & Thomas Dörner. (2021). B cells in systemic lupus erythematosus. Current Opinion in Rheumatology. 34(2). 125–132. 22 indexed citations
14.
Rincón-Arévalo, Héctor, Annika Wiedemann, Ana‐Luisa Stefanski, et al.. (2021). Deep Phenotyping of CD11c+ B Cells in Systemic Autoimmunity and Controls. Frontiers in Immunology. 12. 635615–635615. 47 indexed citations
15.
Szelinski, Franziska, et al.. (2020). Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility. Lara D. Veeken. 59(11). 3435–3442. 27 indexed citations
16.
Gatto, Mariele, Annika Wiedemann, Karin Reiter, et al.. (2019). Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis. Frontiers in Immunology. 10. 29–29. 8 indexed citations
17.
Szelinski, Franziska, Eva Schrezenmeier, Ana‐Luisa Stefanski, et al.. (2019). Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases. Frontiers in Immunology. 10. 2136–2136. 42 indexed citations
18.
19.
20.
Rose, Thomas, Franziska Szelinski, Karin Reiter, et al.. (2016). SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome. RMD Open. 2(2). e000292–e000292. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaqun Zhu Breakdown of academic impact, for papers by Olof Berggren Breakdown of academic impact, for papers by Lucyna Korman Breakdown of academic impact, for papers by Alessandra Penatti Breakdown of academic impact, for papers by Kamini Shah Breakdown of academic impact, for papers by Ling‐Ying Lu Breakdown of academic impact, for papers by Konstantia-Maria Chavele Breakdown of academic impact, for papers by Quentin Simon Breakdown of academic impact, for papers by Takayoshi Morita Breakdown of academic impact, for papers by Afroditi Boulougoura
Rankless by CCL
2026